CY1115197T1 - ELISA FOR VEGF - Google Patents
ELISA FOR VEGFInfo
- Publication number
- CY1115197T1 CY1115197T1 CY20141100451T CY141100451T CY1115197T1 CY 1115197 T1 CY1115197 T1 CY 1115197T1 CY 20141100451 T CY20141100451 T CY 20141100451T CY 141100451 T CY141100451 T CY 141100451T CY 1115197 T1 CY1115197 T1 CY 1115197T1
- Authority
- CY
- Cyprus
- Prior art keywords
- vegf
- diagnostic
- kits
- prognostic marker
- elisa
- Prior art date
Links
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 abstract 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 abstract 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 abstract 3
- 239000003550 marker Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000013610 patient sample Substances 0.000 abstract 1
- 238000003118 sandwich ELISA Methods 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Η δραστικότητα αγγειακού ενδοθηλιακού αυξητικού παράγοντα (VEGF) στην κυκλοφορία αίματος ή σε άλλο βιολογικό δείγμα ασθενούς μπορεί να χρησιμεύσει ως διαγνωστικός και προγνωστικός δείκτης για καρκίνο, διαβήτη, καρδιακές παθήσεις, και άλλες παθολογίες. Παρέχονται μέθοδοι και κιτ ELΙSA αντισωμάτων-σάντουιτς για VEGF ως αντιγόνο για ανίχνευση επιπέδων τύπων VEGF σε βιολογικά δείγματα από ζωικά πρότυπα και ανθρώπους ασθενείς και μπορούν να χρησιμοποιηθούν ως διαγνωστικός/προγνωστικός δείκτης.Vascular endothelial growth factor (VEGF) activity in the bloodstream or other biological patient sample can serve as a diagnostic and prognostic marker for cancer, diabetes, heart disease, and other pathologies. Methods and sandwich ELISA antibody kits and kits are provided as antigen for detecting levels of VEGF types in biological samples from animal models and human patients and can be used as a diagnostic / prognostic marker.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82820306A | 2006-10-04 | 2006-10-04 | |
| EP07868362.0A EP2069798B1 (en) | 2006-10-04 | 2007-10-03 | Elisa for vegf |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115197T1 true CY1115197T1 (en) | 2017-01-04 |
Family
ID=58461535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100451T CY1115197T1 (en) | 2006-10-04 | 2014-06-20 | ELISA FOR VEGF |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1115197T1 (en) |
-
2014
- 2014-06-20 CY CY20141100451T patent/CY1115197T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009003562A (en) | Elisa for vegf. | |
| ATE315789T1 (en) | ELISA FOR VEGF | |
| Bahadır et al. | Applications of electrochemical immunosensors for early clinical diagnostics | |
| Potter-Baker et al. | A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models | |
| WO2005108989A3 (en) | Assay for antibodies | |
| DE60207979D1 (en) | Method and device for determining tissue specificity of free DNA in body fluids | |
| WO2006127861A3 (en) | Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations | |
| WO2006091412A3 (en) | Adamts-7 as a biomarker for cancers of epithelial origin | |
| DE602006018578D1 (en) | DIAGNOSIS AND PROGNOSIS OF BUBBLE CANCER. | |
| EP2550371A4 (en) | PROTEIN AND GENETIC BIOMARKERS FOR REJECTION OF ORGAN TRANSPLANTS | |
| WO2006073682A3 (en) | Diagnostic test | |
| ATE525648T1 (en) | TEST ELEMENT WITH NANOFIBERS | |
| FR2933773B1 (en) | METHOD FOR DETERMINING THE ISOMERASE DISULFIDE PROTEIN FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER | |
| DE602006019262D1 (en) | QUANTITATIVE ASSAYS FOR PDGFR-beta IN BODY FLUIDS | |
| WO2005098433A3 (en) | Diagnostic assays for alzheimer’s disease | |
| RU2010119453A (en) | ASSESSMENT OF DIAGNOSTIC MARKERS | |
| CY1115197T1 (en) | ELISA FOR VEGF | |
| ES2570609T3 (en) | Method for testing aminoacylase 1 for in vitro diagnosis of colorectal cancer | |
| FR2840905B1 (en) | MONOCLONAL ANTI-AURORA-A ANTIBODY, METHOD FOR OBTAINING SAME, AND USES THEREOF IN CANCER DIAGNOSIS AND TREATMENT | |
| ROY et al. | TECHNIQUES IN QUANTIFYING HORMONES IN BIOLOGICAL FLUIDS | |
| CY1112415T1 (en) | THE PROTEIN SERUM AMYLOID P-COMPONENT (SAP, SAMP) AS A PREDICTIVE AND DIAGNOSTIC INDEX FOR TRISCAL 21 CHILDREN'S CHECK (DOWN SYNDROME) | |
| TH106073A (en) | ELISA analysis test for the detection of VEGF | |
| Shuhaibar et al. | A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers | |
| ATE538385T1 (en) | DIGALACTOLIPID ANTIGEN EXPOSED ON THE SURFACE OF API COMPLEX PARASITES AND ITS DIAGNOSTIC AND THERAPEUTIC USE | |
| ITMI20022743A1 (en) | METHOD FOR DETERMINING THE RISK OF APPEARANCE, THE PRESENCE OR THE COURSE OF CANCER DISEASES. |